Abstract
Smokers with co-occurring mental illness or substance use disorders are not designated a disparity group or priority population by most national public health and tobacco control groups.
These smokers fulfill the criteria commonly used to identify groups that merit special attention: targeted marketing by the tobacco industry, high smoking prevalence rates, heavy economic and health burdens from tobacco, limited access to treatment, and longer durations of smoking with less cessation. A national effort to increase surveillance, research, and treatment is needed.
Designating smokers with behavioral health comorbidity a priority group will bring much-needed attention and resources. The disparity in smoking rates among persons with behavioral health issues relative to the general population will worsen over time if their needs remain unaddressed.
ELIMINATING DISPARITIES IN health and health care is a major priority in the United States.1,2 Groups with health disparities are referred to as vulnerable or priority populations and can be defined by factors such as race/ethnicity, socioeconomic status, geography, gender, age, disability status, or sexual orientation.3 The sources of these disparities are complex, rooted in historic and social inequities.4 Cigarette smoking, the leading cause of preventable death, is listed as one of 21 conditions with ongoing health disparities that must be addressed.1 Indeed, as the American Legacy Foundation points out, tobacco is not an equal opportunity killer.5 The criteria organizations such as the Centers for Disease Control and Prevention use to designate a tobacco disparity group are that they experience disproportionate tobacco consumption, disproportionate consequences or health burden from tobacco use, disproportionate economic burden from tobacco use, or limited access to tobacco-related health care.1,6,7 These groups may also be targeted by the tobacco industry with special marketing.6 Increased tobacco consumption may stem from differences in risk for tobacco use initiation or progression, differences in tobacco use prevalence and rates of nicotine dependence, and differences in smoking cessation rates.
Smokers with a co-occurring mental illness or substance use disorder (SUD) have historically been underserved.8–13 Persons with behavioral health conditions, a collective term whose use is increasing because it may reduce stigma, compose a significant subset of smokers in the United States. A recent study found that cigarette smoking prevalence was 37.8% among people with any anxiety disorder, 45.1% among those with any affective disorder, 63.6% among those with a substance use disorder, and only 21.3% among those with no mental disorder.14 Smoking rates have plateaued despite ongoing tobacco control efforts, and clinical data support the concern that public health techniques that have been largely successful in the past may have reduced impact with remaining smokers.15,16 Although population-level data are less consistent on this point, data from both the National Health Interview Survey17 and the National Survey of Drug Use and Health18 suggest that smokers with moderate to high levels of general psychological distress are less likely than those with lower levels to have quit smoking. These data raise the possibility that behavioral health comorbidity may contribute to existing concerns about the impact of current tobacco approaches on today’s smokers.
Surprisingly, most tobacco control Web sites and organizations, such as the Centers for Disease Control and Prevention’s Office on Smoking and Health,19 Healthy People 2020,2 and the American Legacy Foundation,20 do not designate smokers with behavioral health comorbidity as a disparity group or priority population. Understanding and eliminating disparities are such high priorities that these larger organizations have sponsored dedicated spin-off groups, such the National Networks for Tobacco Control and Prevention (sponsored by the Centers for Disease Control and Prevention)21 and the Tobacco Research Network on Disparities (TReND; cosponsored by the National Cancer Institute and American Legacy Foundation).22 These groups have paid only cursory attention to smokers with behavioral health comorbidity.23 For example, these smokers are included on the TReND Web site with a long list of “other historically underserved groups” that includes lesbian, gay, bisexual, and transgender persons; people with disabilities; and the military. (Major tobacco control groups in the United States and their identified disparity populations are listed in Table 1).
TABLE 1—
Disparity Groups Identified by Key Tobacco Control Organizations and Health Opinion Leaders in the United States
| Organization/Report | Source | Racial/Ethnic Minoritiesa | Persons With Low SESb | Pregnant Women | LGBT Persons | Gender | Youths | Older Adults | Military Personnel | Persons With Mental Health and Substance Use Disorders |
| CDC Office on Smoking and Health | http://www.cdc.gov/tobacco/basic_information/health_disparities/index.htm | X | X | X | X | X | X | |||
| National Networks for Tobacco Control and Preventionc | http://www.tobaccopreventionnetworks.org/site/c.ksJPKXPFJpH/b.2588535/k.6D55/Eliminating_Disparities.htm | X | X | X | X | |||||
| Surgeon general’s reports (2000, 2001, 2004, and 2012) | http://www.surgeongeneral.gov/library/index.html | X | X | X | ||||||
| Healthy People 2020 | http://healthypeople.gov/2020/LHI/tobacco.aspx | X | X | X | X | X | ||||
| American Legacy Foundation | http://www.legacyforhealth.org/2165.aspx | X | X | X | X | |||||
| Tobacco Research Network on Disparitiesd | http://www.tobaccodisparities.org | X | X | X | X | X | X | X | X | |
| American Lung Association | http://www.lung.org/stop-smoking/about-smoking/facts-figures/specific-populations.html | X | X | X | X | X | X | X | X | |
| Tobacco Cessation Leadership Network | http://www.tcln.org/cessation/priority-populations.html | X | X | X | ||||||
| Society for Research on Nicotine and Tobacco Tobacco Related Health Disparities Network | http://www.srnt.org/about/networks.cfm | X | ||||||||
| Smoking Cessation Leadership Center | http://smokingcessationleadership.ucsf.edu/BehavioralHealth.htm | X |
Note. CDC = Centers for Disease Control and Prevention; LGBT = lesbian, gay, bisexual, transgender; SES = socioeconomic status.
African American, American Indian, Alaska Native, Asian American, Pacific Islander, and Hispanic.
Indicated by poverty, low education level, unemployment.
Sponsored by CDC.
Cosponsored by the National Cancer Institute and American Legacy Foundation.
REVIEW OF EVIDENCE
This article reviews the literature that supports the need to recognize and identify smokers with behavioral health comorbidity as an important disparity group of tobacco users in the United States today. The validity of designating smokers with comorbid mental illness or SUDs as a priority population is shown by applying each of the criteria that qualify other groups for this attention to the population of smokers with behavioral health comorbidity.
Disproportionate Tobacco Consumption
According to Healthy People 2020, a disparity exists if a health outcome is greater in certain populations.2 In the past 20 years, numerous studies have demonstrated higher rates of ever, daily, and heavy smoking among Americans with mental illness or SUDs than among individuals without these conditions.14,24–27 Studies have documented higher rates of smoking in nearly every type of behavioral health condition.24,25,27–31 Studies of smokers accessing tobacco treatment services in community settings or via quit lines have also indicated that about half of these smokers report a lifetime behavioral health condition.32–37 Comparative smoking prevalence rates for groups classified as tobacco use disparity populations are shown in Table 2.
TABLE 2—
Smoking Prevalence Rates in Identified US Disparity Groups
| Group | Smoking Prevalence Rate, % | Data Source |
| US general population | 19.3–20.6 | 2009–2010 NHIS38,39 |
| Low SES | ||
| Poverty | 31.1–36.5 | 2006–2008 NSDUH,38,39 2009 NHIS,38,39 |
| < high school diploma | 28.5–32.0 | |
| Unemployed | 44.7 | |
| Racial/ethnic minorities | ||
| African American | 21.3–26.9 | 2006–2008 NSDUH, 2009 NHIS38,39 |
| Hispanic | 14.5–22.9 | 2006–2008 NSDUH, 2009 NHIS38,39 |
| American Indian/Alaska Native | 23.2–42.2 | 2006–2008 NSDUH, 2009 NHIS38,39 |
| Asian American | 12.0–14.7 | 2006–2008 NSDUH, 2009 NHIS38,39 |
| Pacific Islander | 16.5 | 2009 NHIS40 |
| Pregnant Women | 12.8 | 2008 PRAMS41 |
| LGBT sexual orientation | 24–48 | State data sources42 |
| Gender | ||
| Men | 21.5–23.5 | 2009–2010 NHIS38,39 |
| Women | 17.3–17.9 | 2009–2010 NHIS38,39 |
| Youths | ||
| High school | 17.2 | 2009 NYTS43 |
| Middle school | 5.2 | 2009 NYTS43 |
| Mental health and substance use disorders | ||
| Mental illness | 40.1 | 2001–2003 NCS,14 2002 NSDUH,44 2005 NHIS17 |
| Substance use | 63.6 | |
| Serious psychological distressa | 41.9–44.5 |
Note. LGBT = lesbian, gay, bisexual, transgender; NCS = National Comorbidity Study; NHIS = National Health Interview Survey; NSDUH = National Survey on Drug Use and Health; NYTS = National Youth Tobacco Survey; PRAMS = Pregnancy Risk Assessment and Monitoring System; SES = socioeconomic status.
Measured by the K6 scale.44
Lasser et al. used data from the 1991 to 1992 National Comorbidity Survey to show that 41% of cigarette smokers met criteria in the past month for some type of mental health condition or addiction (as defined in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision45).24 These findings have been replicated in the past decade.14,26 People with behavioral health comorbidity represent about one third, or 16 million people, of an estimated total 51 million adult smokers in the United States.14 Several states have confirmed higher smoking rates in adults who report poor mental health in Behavioral Risk Factor Surveillance System data.46–48 In at least one state, smoking rates are not decreasing among respondents reporting poor mental health.46
Smokers with comorbid mental illness or SUDs may have more difficulty in quitting, which may contribute to higher prevalence rates. This has been shown in clinical populations as well as in population data.24,25,49,50 There is evidence that not only are current symptoms and illness severity related to quitting smoking, but even a history of a disorder, such as major depression, is linked to lower short- and long-term abstinence.28,51 Specialty tobacco cessation services also have reported that behavioral health comorbidity is a predictor of reduced cessation.33,37,52
Groups with greater risk for tobacco use progression are also considered priority populations. Studies have found that youths with behavioral health comorbidity are more likely to progress to nicotine dependence or daily smoking.53–58 Behavioral health comorbidity is included in a recent US Surgeon General’s report, Preventing Tobacco Use Among Youth and Young Adults,59 although surveillance instruments such as the Global Youth Tobacco Survey60 do not assess depression or mental health.
Disproportionate Health Consequences
The consequences of tobacco use among persons with mental illness or SUDs are considerable: increased morbidity, mortality, and burden of tobacco-related illness relative to those without behavioral disorders. Evidence shows that tobacco contributes to more deaths in this group than does the primary behavioral health disorder.61,62 The 3 major conditions caused by tobacco use are cancer, cardiovascular disease, and respiratory disease, and these illnesses are seen commonly among persons with mental illness or SUDs.1 Mental disorders, even milder ones, are associated with elevated risks of premature mortality.63–65 For those with serious mental illness, this translates into 25 years of reduced life expectancy66,67 with most excess deaths attributable to cardiovascular disease. In a sample of patients with psychosis aged 35 to 54 years, the odds of cardiac-related death were 12 times as high among smokers as among nonsmokers.68 Individuals with serious mental illness have elevated rates of cancer; lung cancer is the most common type in men.69,70 Comorbid medical and behavioral health conditions are likely synergistic, with the cumulative burden, including higher costs, greater than the sum of the individual conditions.62,71
Disproportionate Economic Burden and Purchasing
Like other low-income groups, individuals with behavioral health disorders bear a tremendous economic burden resulting from their tobacco use. Two studies have found that persons with current mental disorders or addictions purchase and consume at least 40% of the cigarettes sold in the United States.24,26 Although price increases and taxation are an important aspect of tobacco control that can reduce smoking prevalence in a population, it is not known to what extent smokers with comorbidity are price sensitive. One analysis estimated that smokers with mental illness were responsive to price, although it did not control for level of dependence, which may be higher in this group.72 Smokers with serious mental illness such as schizophrenia spend a considerable portion of their disability income to buy tobacco.73–75 Although they economize by smoking more generic and discount value brands than do smokers without mental illness,73,76 high cigarette taxes still impose a considerable burden on all low-income smokers.77 In addition, they may also be less sensitive to price if their tobacco consumption is subsidized by their families and caregivers. In a recent survey, 60% of disabled mental health consumers reported that their families bought them tobacco.78 One difficulty in understanding price sensitivity is that smokers with behavioral health comorbidity are not a single group but reflect a large spectrum of illnesses, with varying socioeconomic status and degrees of disability. Smokers with serious mental illness, although perhaps the most financially burdened, represent a relatively small segment (< 10%) of the entire group with behavioral health comorbidity.
Targeted Marketing by the Tobacco Industry
The tobacco industry targets marketing to vulnerable or receptive populations such as young adults, socially disadvantaged groups, and various racial/ethnic groups.79 Ample evidence shows that the tobacco industry segments consumer markets and targets advertising toward psychosocial needs satisfaction. Marketing addresses psychological needs such as stress relief, behavioral arousal, performance enhancement, and obesity reduction.80,81 Evidence from tobacco industry document review reveals targeting to psychologically vulnerable populations, including the mentally ill. Until recently, most psychiatric hospitals sold cigarettes in the hospital store, and they received frequent sales promotions and giveaways from major cigarette companies promoting value brands.82 The tobacco industry also supported efforts to block smoking bans in these settings.83
Reduced Access to Resources
One factor that may be linked to the continued high prevalence of smoking among people with mental illness and SUDs is lack of access to cessation services, particularly in the behavioral health setting. Rates of tobacco documentation and treatment in these settings are very low,9,10 and psychiatrists are less likely than physicians in other specialties to be aware of state-funded tobacco services.11 In psychiatry residency training programs, tobacco education is not a requirement, and only half of programs provide it.84 A survey conducted by the Association of American Medical Colleges found that few psychiatrists reported being very well prepared by previous education to help patients stop smoking, and more than 30% felt that continuing education was unavailable.12
Because many individuals with behavioral health conditions are treated in the primary care setting, strategies are needed to help these smokers in a variety of health care settings. Models for collaborative care management are increasingly being used to deliver evidence-based practices for behavioral health problems in mental health settings.85 Some models for medical health homes are locating behavioral health professionals in primary care physicians' offices to provide better access to services; this may provide opportunities for addressing tobacco addiction.
DISPARITY DESIGNATION
Smokers with behavioral health comorbidity clearly meet the definition of a tobacco use disparity group. In fact, they fulfill all the criteria commonly used to designate such groups. Individuals with behavioral health comorbidity are a considerable portion of the remaining smokers in the United States. Although the classification of behavioral health comorbidity is broad and inclusive, other disparate groups defined by race or gender are also broad and inclusive. Some groups that have been classified as tobacco use disparity groups have tobacco use prevalence rates that are lower than those of comorbid smokers (Table 2).14,17,38–44 The disparity in smoking rates between persons with behavioral health conditions and the general population may also worsen over time if their needs remain unaddressed.
Effects of Designation
Designation as a priority group is not merely an academic issue. It can lead to greater access to scientific funding and treatment resources, which in turn may lead to the development and evaluation of tailored and therefore more effective smoking cessation interventions. Furthermore, models for integrating smoking cessation services into behavioral health care and outreach models to link smokers with behavioral health comorbidity who are not receiving any health care to services can be developed and tested. Although this has not been measured, it is likely that minimal tobacco control dollars at the state or federal level are being directed toward this group. Several factors likely contribute to the absence of a significant national agenda on behavioral health and smoking comorbidity. National behavioral health organizations have been slow to organize on this issue, and behavioral health advocacy groups have not been advocating for greater access to resources. Research on tobacco use and behavioral health spans at least three separate agencies in the National Institutes of Health (the National Institute on Drug Abuse, National Institute of Mental Health, and National Cancer Institute), yet not one joint funding announcement or special request for applications for research on this comorbidity has appeared. Partnerships are needed between state tobacco control offices (often located in departments of health) and behavioral health services (often located in departments of human services) to develop effective strategies and share resources.
Finally, lack of attention given to smokers with behavioral health comorbidity may represent stigma, because no other group with such profound evidence of tobacco devastation has been neglected in a similar way. Prejudice and discrimination are believed to be important contributors to the production of health disparities,4 and behavioral health disorders carry society’s most negative stigma. Unconscious forms of bias exist even in the absence of overt expressions of prejudicial attitudes, and, although these stigma models originated from studies of race, they are increasingly being applied to populations with mental illness or obesity.86 Stigma contributes to the belief that comorbid smokers cannot or will not give up tobacco because it is “all they have.” Evidence for this is found in the scarcity of smoking cessation activity or discussion at prominent conferences and publications in behavioral health recovery. We have seen groups that champion recovery models for overcoming behavioral health disorders nonetheless subtly undermine smokers’ sense that they can recover from tobacco dependence as well. Interestingly, similar claims are not made to justify use of other addicting and deadly substances in behavioral health care.
A limitation of our review was that data sources for this population are incomplete. Many gaps exist in the current literature, and we have better estimates of tobacco use prevalence in other segments of the population. Making comorbid smokers a priority population, however, would greatly increase surveillance and improve existing data collection instruments to ensure that behavioral health comorbidity is being assessed in national data sets that track tobacco use. Reaching the national Healthy People 2020 goal2 of eliminating health disparities related to tobacco use will necessitate improved collection and use of standardized and qualitative data to identify disparities in both health outcomes and efficacy of prevention programs among various population groups.
Need for a National Effort
Smokers with behavioral health comorbidity have received attention in peer-reviewed publications in relevant journals, but these represent the efforts of individual scientists and are not reflective of a unified or purposeful effort. Our review of key public health and tobacco control Web sites showed that this issue is still largely invisible. The efforts of the Smoking Cessation Leadership Center87 are an exception, but this is not enough. Since 2001, the Centers for Disease Control and Prevention’s National Tobacco Control Program has worked with states to develop strategic plans to address disparities. It is not known how many of these plans included smokers with behavioral health comorbidity because this was not a requirement to receive federal funding. Merely allowing states to take the initiative will not be enough: a national plan is critically needed for this major public health issue. A document such as a surgeon general’s report on this topic would bring national attention to this issue.
A critical aspect of designating a disparity group is recognizing that standard or population-based approaches that benefit many people may not work. California, which has the lowest smoking rates in the country, has found that statewide tobacco control approaches may not benefit some disparity groups, such as lesbian, gay, bisexual, and transgender persons and military personnel.88 The group of people with behavioral health issues likely comprises many subgroups with important distinctions stemming from diagnosis, illness severity, and functional impairment that are best addressed by tailored tobacco control approaches. When working with vulnerable tobacco-using populations, it is critical to understand in detail the cultural context of smoking and quitting, which may be best ascertained through qualitative research.89
Resources should be directed toward those with greatest need. The only group that approximates the smoking prevalence rates of comorbid smokers is low-income smokers, and presumably these groups overlap to some degree. Future tobacco control efforts should prioritize low-income and comorbid smokers. Funding decisions should reflect current need and not merely replicate activities of the past. In addition to enhanced surveillance, priority should be given to tobacco control funding that seeks to answer basic questions about access to treatment, effectiveness of evidence-based treatments, and barriers to cessation for smokers with behavioral health comorbidity. Studies are also needed to assess whether this group benefits from traditional tobacco control techniques, such as taxation and clean indoor air legislation. A national effort to address educational deficits and policies to promote tobacco treatment by behavioral health professionals is also needed.
Behavioral health is one of only three groups meeting all criteria for a tobacco use disparity group (Table 3). Although racial/ethnic minorities and persons with low socioeconomic status also meet all criteria, they meet criteria with lower severity. Smoking prevalence is higher among persons with behavioral health conditions than among nearly all other groups that bear disparity burdens. We are, therefore, confident that smokers with behavioral health comorbidity are the disparity group most deserving of attention in the United States today.
TABLE 3—
Criteria Met by Tobacco Use Disparity Groups in the United States
| Criterion | Racial/Ethnic Minoritiesa | Persons With Low SESb | Pregnant Women | LGBT Persons | Gender | Youths | Persons With Mental Health and Substance Use Disorders |
| Differences in risk for tobacco use initiation or progression | X | X | X | X | X | ||
| Differences in tobacco use prevalence | X | X | X | X | |||
| Differences in rates of nicotine dependence | X | X | X | X | X | ||
| Differences in cessation rates | X | X | X | X | X | ||
| Disproportionate health burden from tobacco use | X | X | X | X | |||
| Disproportionate economic burden from tobacco use | X | X | X | X | X | ||
| Disproportionate tobacco purchasing | X | X | X | X | X | X | |
| Targeted by the tobacco industry with special marketing | X | X | X | X | X | X | |
| Reduced access to resources including treatment | X | X | X |
Note. LGBT = lesbian, gay, bisexual, transgender; SES = socioeconomic status.
Source. Centers for Disease Control and Prevention.1,6,7
African American, American Indian, Alaska Native, Asian American, Pacific Islander, and Hispanic.
Indicated by poverty, low education level, unemployment.
Acknowledgments
This work was supported in part by grants from the National Institute on Drug Abuse (1R34DA030652 to M. L. S. and 5K23DA025049 to N. C.). J. M. Williams is supported in part by the New Jersey Department of Human Services, Division of Mental Health and Addictions Services. M. L. Steinberg is supported in part by the New Jersey Department of Health. J. M. Williams and M. L. Steinberg have received grant support from Pfizer.
References
- 1.Frieden TR Centers for Disease Control and Prevention. Forward: CDC Health Disparities and Inequalities Report—United States, 2011. MMWR Surveill Summ. 2011;60(suppl):1–2. [PubMed] [Google Scholar]
- 2. US Department of Health and Human Services, Office of Disease Prevention and Health Promotion. Healthy People 2020. Available at: http://www.healthypeople.gov/2020/topicsobjectives2020/pdfs/HP2020objectives.pdf. Accessed August 6, 2012.
- 3.Agency for Healthcare Research and Quality. National Healthcare Disparities Report 2011. Rockville, MD: US Department of Health and Human Services; 2012. AHRQ publication 12–0006. Available at: http://www.ahrq.gov/qual/qrdr11.htm. Accessed August 6, 2012. [Google Scholar]
- 4.Institute of Medicine. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: National Academies Press; 2002. [PubMed] [Google Scholar]
- 5. Tobacco is not an equal opportunity killer: new CDC study sheds light on smoking rates by industry and occupation. American Legacy Foundation. 2011. Available at: http://www.legacyforhealth.org/4729.aspx. Accessed March 19, 2013.
- 6.Office on Smoking and Health. Best Practices for Comprehensive Tobacco Control Programs—2007. Atlanta, GA: Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion; 2007. [Google Scholar]
- 7.Office on Smoking and Health. Tobacco Use Among U.S. Racial/Ethnic Minority Groups: A Report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion; 1998. [Google Scholar]
- 8.Williams JM, Delnevo C, Ziedonis DM. The unmet needs of smokers with mental illness or addiction. In: Bearman P, Neckerman KM, Wright L, editors. After Tobacco: What Would Happen If Americans Stopped Smoking? New York, NY: Columbia University Press; 2011. pp. 367–380. [Google Scholar]
- 9.Peterson AL, Hryshko-Mullen AS, Cortez Y. Assessment and diagnosis of nicotine dependence in mental health settings. Am J Addict. 2003;12(3):192–197. [PubMed] [Google Scholar]
- 10.Montoya ID, Herbeck DM, Svikis DS, Pincus HA. Identification and treatment of patients with nicotine problems in routine clinical psychiatry practice. Am J Addict. 2005;14(5):441–454. doi: 10.1080/10550490500247123. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Steinberg MB, Alvarez MS, Delnevo CD, Kaufman I, Cantor JC. Disparity of physicians’ utilization of tobacco treatment services. Am J Health Behav. 2006;30(4):375–386. doi: 10.5555/ajhb.2006.30.4.375. [DOI] [PubMed] [Google Scholar]
- 12.Association of American Medical Colleges. Physician behavior and practice patterns related to smoking cessation. 2007. Available at: http://www.aamc.org/workforce/smoking-cessation-summary.pdf. Accessed August 1, 2012.
- 13.Friedmann PD, Jiang L, Richter KP. Cigarette smoking cessation services in outpatient substance abuse treatment programs in the United States. J Subst Abuse Treat. 2008;34(2):165–172. doi: 10.1016/j.jsat.2007.02.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Lawrence D, Mitrou F, Zubrick SR. Smoking and mental illness: results from population surveys in Australia and the United States. BMC Public Health. 2009;9:285. doi: 10.1186/1471-2458-9-285. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Burns DM, Warner KE. Those Who Continue to Smoke: Is Achieving Abstinence Harder and Do We Need to Change Our Interventions? Bethesda, MD: National Cancer Institute; 2003. Smokers who have not quit: is cessation more difficult and should we change our strategies? pp. 11–31. Smoking and Tobacco Control Monograph 15. [Google Scholar]
- 16.Hughes JR. The hardening hypothesis: is the ability to quit decreasing due to increasing nicotine dependence? A review and commentary. Drug Alcohol Depend. 2011;117(2–3):111–117. doi: 10.1016/j.drugalcdep.2011.02.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Lawrence D, Mitrou F, Zubrick SR. Non-specific psychological distress, smoking status and smoking cessation: United States National Health Interview Survey 2005. BMC Public Health. 2011;11:256. doi: 10.1186/1471-2458-11-256. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Hagman BT, Delnevo CD, Hrywna M, Williams JM. Tobacco use among those with serious psychological distress: findings from the National Survey of Drug Use and Health, 2002. Addict Behav. 2008;33(4):582–592. doi: 10.1016/j.addbeh.2007.11.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Smoking and tobacco use. Centers for Disease Control and Prevention. Available at: http://www.cdc.gov/tobacco/basic_information/health_disparities/index.htm. Accessed August 1, 2012.
- 20.Investigating tobacco-related disparities among vulnerable populations. American Legacy Foundation. Available at: http://www.legacyforhealth.org/what-we-do/tobacco-control-research/research-evaluation/investigating-tobacco-related-disparities/(language)/eng-US. Accessed August 1, 2012.
- 21.Priority populations. National Networks for Tobacco Control and Prevention. Available at: http://www.tobaccopreventionnetworks.org/site/c.ksJPKXPFJpH/b.2582389/k.737A/Priority_Population_Info.htm. Accessed August 1, 2012.
- 22.Fast facts. Tobacco Research Network on Disparities. Available at: http://tobaccodisparities.org/index.php/fast-facts. Accessed August 1, 2012.
- 23.Fagan P, King G, Lawrence D et al. Eliminating tobacco-related health disparities: directions for future research. Am J Public Health. 2004;94(2):211–217. doi: 10.2105/ajph.94.2.211. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness: a population-based prevalence study. JAMA. 2000;284(20):2606–2610. doi: 10.1001/jama.284.20.2606. [DOI] [PubMed] [Google Scholar]
- 25.Hapke U, Schumann A, Rumpf HJ, John U, Konerding U, Meyer C. Association of smoking and nicotine dependence with trauma and posttraumatic stress disorder in a general population sample. J Nerv Ment Dis. 2005;193(12):843–846. doi: 10.1097/01.nmd.0000188964.83476.e0. [DOI] [PubMed] [Google Scholar]
- 26.Grant BF, Hasin DS, Chou SP, Stinson FS, Dawson DA. Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2004;61(11):1107–1115. doi: 10.1001/archpsyc.61.11.1107. [DOI] [PubMed] [Google Scholar]
- 27.Hughes JR, Hatsukami DK, Mitchell JE, Dahlgren LA. Prevalence of smoking among psychiatric outpatients. Am J Psychiatry. 1986;143(8):993–997. doi: 10.1176/ajp.143.8.993. [DOI] [PubMed] [Google Scholar]
- 28.Pratt LA, Brody DJ. Depression and Smoking in the US Household Population Aged 20 and Over, 2005–2008. Hyattsville, MD: National Center for Health Statistics; 2010. NCHS data brief, vol. 34. [PubMed] [Google Scholar]
- 29.de Leon J, Diaz FJ. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res. 2005;76(2–3):135–157. doi: 10.1016/j.schres.2005.02.010. [DOI] [PubMed] [Google Scholar]
- 30.McCabe RE, Chudzik SM, Antony MM, Young L, Swinson RP, Zolvensky MJ. Smoking behaviors across anxiety disorders. J Anxiety Disord. 2004;18(1):7–18. doi: 10.1016/j.janxdis.2003.07.003. [DOI] [PubMed] [Google Scholar]
- 31.Pulay AJ, Stinson FS, Ruan WJ et al. The relationship of DSM-IV personality disorders to nicotine dependence—results from a national survey. Drug Alcohol Depend. 2010;108(1–2):141–145. doi: 10.1016/j.drugalcdep.2009.12.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Foulds J, Gandhi KK, Steinberg MB et al. Factors associated with quitting smoking at a tobacco dependence treatment clinic. Am J Health Behav. 2006;30(4):400–412. doi: 10.5555/ajhb.2006.30.4.400. [DOI] [PubMed] [Google Scholar]
- 33.Piper ME, Smith SS, Schlam TR et al. Psychiatric disorders in smokers seeking treatment for tobacco dependence: relations with tobacco dependence and cessation. J Consult Clin Psychol. 2010;78(1):13–23. doi: 10.1037/a0018065. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Hays JT, Croghan IT, Schroeder DR et al. Residential treatment compared with outpatient treatment for tobacco use and dependence. Mayo Clin Proc. 2011;86(3):203–209. doi: 10.4065/mcp.2010.0703. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Han ES, Foulds J, Steinberg MB et al. Characteristics and smoking cessation outcomes of patients returning for repeat tobacco dependence treatment. Int J Clin Pract. 2006;60(9):1068–1074. doi: 10.1111/j.1742-1241.2006.01077.x. [DOI] [PubMed] [Google Scholar]
- 36.Lemmonds CA, Mooney M, Reich B, Hatsukami D. Characteristics of cigarette smokers seeking treatment for cessation versus reduction. Addict Behav. 2004;29(2):357–364. doi: 10.1016/j.addbeh.2003.08.049. [DOI] [PubMed] [Google Scholar]
- 37.Hebert KK, Cummins SE, Hernández S, Tedeschi GJ, Zhu SH. Current major depression among smokers using a state quitline. Am J Prev Med. 2011;40(1):47–53. doi: 10.1016/j.amepre.2010.09.030. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Centers for Disease Control and Prevention. Vital signs: current cigarette smoking among adults ≥ 18—United States, 2009. MMWR Morb Mortal Wkly Rep. 2010;59(35):1135–1140. [PubMed] [Google Scholar]
- 39.Centers for Disease Control and Prevention. Vital signs: current cigarette smoking among adults ≥ 18 years—United States, 2005–2010. MMWR Morb Mortal Wkly Rep. 2011;60(35):1207–1212. [PubMed] [Google Scholar]
- 40.Pleis JR, Ward BW, Lucas JW. Summary health statistics for US adults: National Health Interview Survey, 2009. Vital Health Stat. 2010;10(249):1–207. [PubMed] [Google Scholar]
- 41.PRAMS and smoking. Centers for Disease Control and Prevention. 2012. Available at: http://www.cdc.gov/prams/tobaccoandprams.htm. Accessed August 1, 2012.
- 42. American Legacy Foundation. Legacy for longer healthier lives: lesbian, gay, bisexual, and transgender (LGBT) communities and smoking. 2011. Available at: http://www.legacyforhealth.org/http://www.legacyforhealth.org/PDFPublications/LGBTfactsheet.pdf. Accessed August 1, 2012.
- 43.Centers for Disease Control and Prevention. Tobacco use among middle and high school students—United States, 2000–2009. MMWR Morb Mortal Wkly Rep. 2010;59(33):1063–1068. [PubMed] [Google Scholar]
- 44.Hagman BT, Delnevo CD, Hrywna M, Williams JM. Tobacco use among those with serious psychological distress: Findings from the National Survey of Drug Use and Health, 2002. Addict Behav. 2008;33(4):582–592. doi: 10.1016/j.addbeh.2007.11.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000. 2000. [Google Scholar]
- 46.New York State Department of Health. Adults in New York who report poor mental health are twice as likely to smoke cigarettes. 2012 Available at: http://www.health.ny.gov/prevention/tobacco_control/reports/statshots/volume5/n2_mental_health_and_smoking_prevalence.pdf. Accessed August 1, 2012. [Google Scholar]
- 47.Montana Department of Public Health and Human Services Public Health and Safety Division. Montana state public health assessment. 2012 Available at: http://www.dphhs.mt.gov/publichealth/documents/StatePublicHealthAssessment2012.pdf. Accessed August 1, 2012. [Google Scholar]
- 48.Center for Health Data and Analysis. Tobacco Use and Health Risks Among Rhode Island Adults in 2006. Providence, RI: Rhode Island Department of Health; 2007. [Google Scholar]
- 49.Humfleet GL, Prochaska JJ, Mengis M et al. Preliminary evidence of the association between the history of childhood attention-deficit/hyperactivity disorder and smoking treatment failure. Nicotine Tob Res. 2005;7(3):453–460. doi: 10.1080/14622200500125310. [DOI] [PubMed] [Google Scholar]
- 50.Agrawal A, Sartor C, Pergadia ML, Huizink AC, Lynskey MT. Correlates of smoking cessation in a nationally representative sample of U.S. adults. Addict Behav. 2008;33(9):1223–1226. doi: 10.1016/j.addbeh.2008.04.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Hitsman B, Papandonatos GD, McChargue DE et al. Past major depression and smoking cessation outcome: a systematic review and meta-analysis update. Addiction. 2012;108(2):294–306. doi: 10.1111/add.12009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Ferguson JA, Patten CA, Schroeder DR, Offord KP, Eberman KM, Hurt RD. Predictors of 6-month tobacco abstinence among 1224 cigarette smokers treated for nicotine dependence. Addict Behav. 2003;28(7):1203–1218. doi: 10.1016/s0306-4603(02)00260-5. [DOI] [PubMed] [Google Scholar]
- 53.Breslau N, Novak SP, Kessler RC. Psychiatric disorders and stages of smoking. Biol Psychiatry. 2004;55(1):69–76. doi: 10.1016/s0006-3223(03)00317-2. [DOI] [PubMed] [Google Scholar]
- 54.Breslau N. Psychiatric comorbidity of smoking and nicotine dependence. Behav Genet. 1995;25(2):95–101. doi: 10.1007/BF02196920. [DOI] [PubMed] [Google Scholar]
- 55.Dierker LC, Avenevoli S, Stolar M, Merikangas KR. Smoking and depression: an examination of mechanisms of comorbidity. Am J Psychiatry. 2002;159(6):947–953. doi: 10.1176/appi.ajp.159.6.947. [DOI] [PubMed] [Google Scholar]
- 56.Patton GC, Carlin JB, Coffey C, Wolfe R, Hibbert M, Bowes G. Depression, anxiety, and smoking initiation: a prospective study over 3 years. Am J Public Health. 1998;88(10):1518–1522. doi: 10.2105/ajph.88.10.1518. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Chilcoat HD, Breslau N. Pathways from ADHD to early drug use. J Am Acad Child Adolesc Psychiatry. 1999;38(11):1347–1354. doi: 10.1097/00004583-199911000-00008. [DOI] [PubMed] [Google Scholar]
- 58.Kushner MG, Menary KR, Maurer EW, Thuras P. Greater elevation in risk for nicotine dependence per pack of cigarettes smoked among those with an anxiety disorder. J Stud Alcohol Drugs. 2012;73(6):920–924. doi: 10.15288/jsad.2012.73.920. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Office on Smoking and Health. Preventing Tobacco Use Among Youth and Young Adults: A Report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion; 2012. [PubMed] [Google Scholar]
- 60.Global Youth Tobacco Survey Collaborative Group. Tobacco use among youth: a cross-country comparison. Tob Control. 2002;11(3):252–270. doi: 10.1136/tc.11.3.252. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Hurt RD, Offord KP, Croghan IT et al. Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort. JAMA. 1996;275(14):1097–1103. doi: 10.1001/jama.275.14.1097. [DOI] [PubMed] [Google Scholar]
- 62.Druss BG, Zhao L, Von Esenwein S, Morrato EH, Marcus SC. Understanding excess mortality in persons with mental illness: 17-year follow up of a nationally representative US survey. Med Care. 2011;49(6):599–604. doi: 10.1097/MLR.0b013e31820bf86e. [DOI] [PubMed] [Google Scholar]
- 63.Felker B, Yazel JJ, Short D. Mortality and medical comorbidity among psychiatric patients: a review. Psychiatr Serv. 1996;47(12):1356–1363. doi: 10.1176/ps.47.12.1356. [DOI] [PubMed] [Google Scholar]
- 64.Goodell S, Druss BG, Walker ER. Mental disorders and medical comorbidity. Robert Wood Johnson Foundation. 2011. Research synthesis report 21. Available at: http://www.rwjf.org/files/research/021011.policysynthesis.mentalhealth.report.pdf. Accessed August 1, 2012.
- 65.Russ TC, Stamatakis E, Hamer M, Starr JM, Kivimäki M, Batty GD. Association between psychological distress and mortality: individual participant pooled analysis of 10 prospective cohort studies. BMJ. 2012;345 doi: 10.1136/bmj.e4933. e4933. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Medical Directors Council. Morbidity and Mortality in People with Serious Mental Illness. Alexandria, VA: National Association of State Mental Health Program Directors; 2006. Available at: http://www.nasmhpd.org/general_files/publications/med_directors_pubs. Accessed August 1, 2012. [Google Scholar]
- 67.Miller BJ, Paschall CB, 3rd, Svendsen DP. Mortality and medical comorbidity among patients with serious mental illness. Psychiatr Serv. 2006;57(10):1482–1487. doi: 10.1176/ps.2006.57.10.1482. [DOI] [PubMed] [Google Scholar]
- 68.Kelly DL, McMahon RP, Wehring HJ et al. Cigarette smoking and mortality risk in people with schizophrenia. Schizophr Bull. 2011;37(4):832–838. doi: 10.1093/schbul/sbp152. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Tran E, Rouillon F, Loze JY et al. Cancer mortality in patients with schizophrenia: an 11-year prospective cohort study. Cancer. 2009;115(15):3555–3562. doi: 10.1002/cncr.24383. [DOI] [PubMed] [Google Scholar]
- 70.McGinty EE, Zhang Y, Guallar E et al. Cancer incidence in a sample of Maryland residents with serious mental illness. Psychiatr Serv. 2012;63(7):714–717. doi: 10.1176/appi.ps.201100169. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Stein MB, Cox BJ, Afifi TO, Belik SL, Sareen J. Does co-morbid depressive illness magnify the impact of chronic physical illness? A population-based perspective. Psychol Med. 2006;36(5):587–596. doi: 10.1017/S0033291706007239. [DOI] [PubMed] [Google Scholar]
- 72.Saffer H, Dave D. Cambridge, MA: National Bureau of Economic Research; 2002. Mental illness and the demand for alcohol, cocaine, and cigarettes. NBER working paper 8699. [Google Scholar]
- 73.Steinberg ML, Williams JM, Ziedonis DM. Financial implications of cigarette smoking among individuals with schizophrenia. Tob Control. 2004;13(2):206. [PMC free article] [PubMed] [Google Scholar]
- 74.McCreadie RG, Kelly C. Patients with schizophrenia who smoke. Private disaster, public resource. Br J Psychiatry. 2000;176:109. doi: 10.1192/bjp.176.2.109. [DOI] [PubMed] [Google Scholar]
- 75.Wilton R. Putting policy into practice? Poverty and people with serious mental illness. Soc Sci Med. 2004;58(1):25–39. doi: 10.1016/s0277-9536(03)00148-5. [DOI] [PubMed] [Google Scholar]
- 76.Williams JM, Gandhi KK, Steinberg ML, Foulds J, Ziedonis DM, Benowitz NL. Higher nicotine and carbon monoxide levels in menthol cigarette smokers with and without schizophrenia. Nicotine Tob Res. 2007;9(8):873–881. doi: 10.1080/14622200701484995. [DOI] [PubMed] [Google Scholar]
- 77.Farrelly MC, Nonnemaker JM, Watson KA. The consequences of high cigarette excise taxes for low-income smokers. PLoS ONE. 2012;7(9):e43838. doi: 10.1371/journal.pone.0043838. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Williams JM, Dwyer M, Verna M et al. Evaluation of the CHOICES program of peer-to-peer tobacco education and advocacy. Community Ment Health J. 2011;47(3):243–251. doi: 10.1007/s10597-010-9310-8. [DOI] [PubMed] [Google Scholar]
- 79.Barbeau EM, Wolin KY, Naumova EN, Balbach E. Tobacco advertising in communities: associations with race and class. Prev Med. 2005;40(1):16–22. doi: 10.1016/j.ypmed.2004.04.056. [DOI] [PubMed] [Google Scholar]
- 80.Cook BL, Wayne GF, Keithly L, Connolly G. One size does not fit all: how the tobacco industry has altered cigarette design to target consumer groups with specific psychological and psychosocial needs. Addiction. 2003;98(11):1547–1561. doi: 10.1046/j.1360-0443.2003.00563.x. [DOI] [PubMed] [Google Scholar]
- 81.Anderson SJ, Glantz SA, Ling PM. Emotions for sale: cigarette advertising and women’s psychosocial needs. Tob Control. 2005;14(2):127–135. doi: 10.1136/tc.2004.009076. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Apollonio DE, Malone RE. Marketing to the marginalised: tobacco industry targeting of the homeless and mentally ill. Tob Control. 2005;14(6):409–415. doi: 10.1136/tc.2005.011890. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Prochaska JJ, Hall SM, Bero LA. Tobacco use among individuals with schizophrenia: what role has the tobacco industry played? Schizophr Bull. 2008;34(3):555–567. doi: 10.1093/schbul/sbm117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Prochaska JJ, Fromont SC, Louie AK, Jacobs MH, Hall SM. Training in tobacco treatments in psychiatry: a national survey of psychiatry residency training directors. Acad Psychiatry. 2006;30(5):372–378. doi: 10.1176/appi.ap.30.5.372. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Fortney J, Enderle M, McDougall S et al. Implementation outcomes of evidence-based quality improvement for depression in VA community based outpatient clinics. Implement Sci. 2012;7:30. doi: 10.1186/1748-5908-7-30. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Stuber J, Meyer I, Link B. Stigma, prejudice, discrimination and health. Soc Sci Med. 2008;67(3):351–357. doi: 10.1016/j.socscimed.2008.03.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Behavioral health: mental health and substance use disorders. Smoking Cessation Leadership Center. Available at: http://smokingcessationleadership.ucsf.edu/BehavioralHealth.htm. Accessed August 1, 2012.
- 88.Al-Delaimy WK, White MM, Mills AL . Final Summary Report of: Two Decades of the California Tobacco Control Program: California Tobacco Survey, 1990–2008. La Jolla, CA: University of California, San Diego; 2010. [Google Scholar]
- 89.Goldade K, Burgess D, Olayinka A, Whembolua GL, Okuyemi KS. Applying anthropology to eliminate tobacco-related health disparities. Nicotine Tob Res. 2012;14(6):631–638. doi: 10.1093/ntr/ntr270. [DOI] [PMC free article] [PubMed] [Google Scholar]
